Virtual Medical Academy

Overview

This webinar aims to support the establishment and scale-up of Type 1 Diabetes (T1D) screening clinics across the Kingdom of Saudi Arabia by bringing together healthcare leaders, endocrinologists, primary care physicians, and public health stakeholders. The session will provide an overview of the importance of early detection of T1D through autoantibody screening, including discussion on the burden of Type 1 Diabetes in Saudi Arabia and the clinical, public health, and patient-centered benefits of screening. It will also showcase successful screening clinic models currently implemented in Saudi Arabia and highlight best practices related to patient identification, referral pathways, clinical workflows, family engagement, data collection, and multidisciplinary collaboration.

This Activity for

Resident / Fellow
Physician

What I will learn?

• Describe the epidemiological, clinical, and healthcare burden of T1D and the potential impact of early detection on patient outcomes.

• Explain the role of islet autoantibody testing in identifying individuals at risk of developing T1D.

• Identify key components of effective T1D screening, referral, and follow-up pathways based on current evidence and local practice.

• Apply appropriate screening and monitoring approaches to individuals identified as being at increased risk of T1D.

• Evaluate implementation considerations for establishing or scaling T1D screening clinics within healthcare organizations.

• Develop strategies to strengthen collaboration among endocrinologists, primary care providers, laboratory teams, and healthcare administrators to support T1D screening and early intervention.